I couldn't agree more. With the safety profile, other drugs not having successful trials in severe/critical, papers getting published, massive numbers of cases globally, a new physicians brain trust for those on the front lines, IMO
enrollment now should get more traction.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.